Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
NasdaqGS - Delayed Quote USD

Clover Health Investments, Corp. (CLOV)

Compare
3.1000 -0.1000 (-3.13%)
At close: August 28 at 4:00 PM EDT
2.9800 -0.12 (-3.87%)
After hours: August 28 at 7:59 PM EDT
Loading Chart for CLOV
DELL

Clover Health Investments, Corp. Overview Healthcare Plans / Healthcare

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

www.cloverhealth.com/en/

552

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLOV

View More

Performance Overview: CLOV

Trailing total returns as of 8/28/2024, which may include dividends or other distributions. Benchmark is

S&P 500
.

YTD Return

CLOV
225.63%
S&P 500
17.24%

1-Year Return

CLOV
146.03%
S&P 500
26.93%

3-Year Return

CLOV
64.00%
S&P 500
24.01%

5-Year Return

CLOV
69.22%
S&P 500
83.87%

Compare To: CLOV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLOV

View More

Valuation Measures

Annual
As of 8/28/2024
  • Market Cap

    1.54B

  • Enterprise Value

    1.17B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.72

  • Price/Book (mrq)

    4.75

  • Enterprise Value/Revenue

    0.56

  • Enterprise Value/EBITDA

    -0.65

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.92%

  • Return on Assets (ttm)

    -6.50%

  • Return on Equity (ttm)

    -36.85%

  • Revenue (ttm)

    2.09B

  • Net Income Avi to Common (ttm)

    -120.77M

  • Diluted EPS (ttm)

    -0.2300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    379.05M

  • Total Debt/Equity (mrq)

    1.23%

  • Levered Free Cash Flow (ttm)

    2.19M

Research Analysis: CLOV

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1.75 Low
2.06 Average
3.1000 Current
2.50
 

Company Insights: CLOV

People Also Watch